Revenue code 636, reported as 0636 on UB-04 and 837I claims, is the pharmacy revenue code for drugs requiring detailed coding. You put it on a facility claim line when a drug has its own HCPCS code, so the payer can see exactly which drug was given, how much, and whether it should be paid on its own.

One drug line with the wrong code, the wrong units, or a missing NDC can turn a five-figure infusion into a denial. That is why a four-digit code deserves more attention than it usually gets.

This guide explains how Medicare, Medicaid, and commercial payers actually apply revenue code 636, with the field-level detail your billing team needs to get paid the first time.

Last reviewed: September 2026. Payment figures reflect CMS rules for calendar year 2026 and the CY 2027 proposed rule.

Revenue Code 636 at a Glance

What Does Revenue Code 636 Mean in Medical Billing?

Every line on a facility claim carries a revenue code. It tells the payer which department or cost center produced the charge: the emergency room, the operating room, the pharmacy. The code beside it describes what was actually done or given. Revenue codes are the “where.” HCPCS and CPT codes are the “what.”

Revenue code 636 sits in the pharmacy range, and the word “detailed” in its descriptor matters. It warns the payer that this line will arrive with a HCPCS code, a unit count, and often an NDC. The payer is expected to price the drug from that detail instead of treating it as general pharmacy cost.

You will see it written as revenue code 636, rev code 636, and 0636. They are the same code. The UB-04 uses a four-digit field, so the leading zero is part of the formal format.

Where 0636 Sits in the 063X Drug Family

Many facilities lean on 0250, 0636, and 0637 and leave the rest of the family alone unless a contract says otherwise.

Which Drugs Belong Under Revenue Code 636?

Any drug a facility gives a patient that carries a specific HCPCS code is a candidate. Common examples include chemotherapy and other antineoplastic agents, monoclonal antibodies and other biologics, IV antibiotics and antivirals with a J-code, and iron or other infusion therapies. Vaccine products with their own code often go here too, with the administration billed on a separate line, though a few payers prefer a different arrangement. New drugs still waiting for a permanent code also land under 0636 when reported with C9399, J3490, or J3590.

What does not belong: saline flushes, standard IV fluids (0258), take-home drugs (0253), oral drugs with no HCPCS code, and supplies. None of them has a drug code of its own, so the “detailed coding” label does not apply.

Revenue Code 636 Under Medicare

Outpatient claims

For hospital outpatient claims under OPPS, Medicare contractor guidance says to report drugs and biologicals with the appropriate HCPCS code under revenue code 0636, whether the drug is separately payable or packaged. That matches NUBC billing guidelines. CMS’s claims processing manual says the same thing in different words: report charges for all drugs, regardless of payment status.

Why bill a drug that will not be paid separately? Because CMS uses claims data to set future rates. Leaving packaged drugs off the claim starves the next year’s rate calculation.

How payment status shapes the line

The status indicator in CMS’s Addendum B decides what happens to a 0636 line:

• K: separately payable, generally at ASP plus 6 percent
• G: pass-through drug with temporary separate payment
• N: packaged into the payment for the associated service

The dividing line for most drugs is a per-day cost threshold. It is $140 for CY 2026, and CMS has proposed keeping $140 for CY 2027. Biosimilars get a break: when the reference biologic is separately paid, the biosimilar can stay separately paid even below the threshold.

Timing matters this year. The CY 2027 proposed rule lists 49 drugs and biologicals whose pass-through status ends on December 31, 2026. Once that happens, each one moves to separate payment or packaging based on cost. If your chargemaster still assumes a drug is status G in January, expect surprises.

Inpatient claims

On Medicare Part A inpatient stays, drug costs are folded into the DRG payment. Revenue code 636 has a narrow job here: reporting blood clotting factors given to hemophilia patients, which Medicare pays as an add-on. CMS requires a qualifying hemophilia diagnosis on the claim and a HCPCS code on the line. When units exceed 99,999, the excess goes on a second 0636 line with the HCPCS code repeated. Other inpatient drugs are reported under general pharmacy codes without HCPCS.

That is the Medicare rule. It is not automatically the rule for every payer.

Commercial Payers and Medicaid Do Not Always Follow Medicare

Commercial reimbursement for 0636 lines follows your contract, not CMS. Some payers want 0636 on any drug with a HCPCS code. Others want it only for separately payable drugs. A common facility approach is 0636 when a HCPCS code exists and 0250 when it does not, because it is easy to audit and maintain. Some commercial contracts also write inpatient terms around 636, which is why coding forums keep fielding the same question. When the contract and Medicare disagree, the contract governs that payer’s claims.

Medicaid adds another layer. Federal drug rebate rules push states to collect NDC data on physician-administered drugs, so most state programs want an NDC on every 0636 line. Some state bulletins go further. A 2025 Indiana Medicaid bulletin, for example, tied payability of a drug procedure code to being billed with revenue code 636.

The practical takeaway: keep a payer-by-payer matrix and update it when contracts renew. Front-end work helps too. Solid insurance eligibility verification should confirm coverage and authorization for the drug itself, not just the visit.

Revenue Code 636 vs 0250 vs 0637

A workable rule of thumb: HCPCS code present, use 0636. No HCPCS code, use 0250. Self-administered, use 0637. Then check the payer contract, because it overrides the rule of thumb.

How to Bill Revenue Code 636 on a UB-04

Units cause more trouble than any other field. Say a patient receives 500 mg of infliximab (Remicade) in a hospital infusion center. J1745 is defined per 10 mg, so the line reports 50 units. Not one vial. Not 500. Billing one unit would collect about two percent of what the facility earned.

When an NDC is required, the format is N4, then the 11-digit NDC with no hyphens, then a unit qualifier, then the quantity. A placeholder looks like N400987654321UN1. On the 837I, the same data travels in the drug identification loop rather than the description field.

Packages often print a 10-digit NDC in 4-4-2, 5-3-2, or 5-4-1 format. Payers want 11 digits in a 5-4-2 layout. Add a leading zero to the first segment for 4-4-2, to the second segment for 5-3-2, and to the third segment for 5-4-1.

Does revenue code 636 need an NDC? Original Medicare generally prices HCPCS-coded drugs without one. Medicaid usually requires it. Commercial payers vary by contract, and the trend is toward requiring it.

Modifiers on 0636 Lines: JW, JZ, JG, and TB

Drug lines often carry modifiers, and missing ones are a leading cause of avoidable denials.

JW reports a discarded amount from a single-dose container and goes on its own line. JZ attests that nothing was discarded. Medicare has required JZ on applicable claims since July 1, 2023. Under OPPS, both apply to separately payable drugs with status indicator G or K, and 340B hospitals still have to report them.

JG and TB identify drugs acquired through the 340B program. For years these modifiers were informational for payment purposes. That may change. In July 2026 CMS proposed paying 340B-acquired drugs at ASP minus 33.4 percent starting in CY 2027. Comments closed August 31, and the proposal was not final at the time of writing. If it is finalized as proposed, modifier accuracy stops being paperwork and starts moving real dollars.

Unclassified and New Drugs: C9399, J3490, and J3590

New drugs often reach patients before they get a permanent HCPCS code. That gap is where the most confusing 0636 errors happen.

Per Medicare contractor guidance, C9399 is reserved for new FDA-approved drugs and biologicals, approved on or after January 1, 2004, that do not yet have a specific HCPCS code. C-codes are temporary. After they expire or get replaced, the drug should move to a not-otherwise-classified code such as J3490 for drugs or J3590 for biologicals. One contractor found hospitals billing sugammadex, diltiazem, and propofol under C9399 when they belonged elsewhere.

A few details worth knowing:

• C9399 drugs go on one line for one unit dose per date of service, with the total quantity noted in the remarks field (FL 80).
• CMS instructions for new unclassified drugs call for the NDC, total quantity administered, and date on the claim.
• That same contractor states that NOC-coded drugs are not separately paid and are treated as inclusive of acquisition cost. Rules can differ by MAC, so check yours.

Common Denials on Revenue Code 636 Lines and How to Fix Them

Most of these start upstream, in the chargemaster or the charge capture workflow, not in the billing office. Fixing the source beats appealing the same denial every month.

When remits come back, review 0636 lines individually. A blended contractual adjustment can hide a drug paid at the wrong rate, and strong payment posting habits catch that early.

A Pre-Bill Checklist for Revenue Code 636

1. Confirm the payer rule. Read the contract and provider manual for pharmacy revenue codes.
2. Check the HCPCS code. CMS updates drug codes quarterly, so refresh your crosswalk every January, April, July, and October.
3. Convert units. Bill by the descriptor, not by the vial.
4. Validate the NDC. Use the 11-digit format where required.
5. Add waste modifiers. JZ or JW on separately payable single-dose drugs.
6. Add 340B modifiers. JG or TB when the drug was 340B-acquired.
7. Check the status indicator. Compare against the current Addendum B, not last year’s.
8. Match the chart. The order, administration record, and waste documentation should agree with the claim.
9. Scrub before you send. A good claim scrubber should hold any 0636 line missing a HCPCS code, units, or NDC. If yours does not, this medical billing software guide explains what to look for.

Why Drug Lines Attract Audits

Drug lines carry high dollar values per line, which makes them natural audit targets. Wrong units, missing waste modifiers, and unsupported 340B reporting are the usual findings. A recurring medical billing audit should sample 0636 claims every quarter. And because repeated overbilling is a legal exposure rather than a simple denial issue, drug billing belongs inside your broader medical billing compliance program.

Frequently Asked Questions

What is revenue code 636?
Revenue code 636 (0636) is the UB-04 pharmacy revenue code for drugs requiring detailed coding. Facilities report it with a HCPCS code so payers can identify the drug, price it, and decide whether it is separately payable.

Is there a difference between revenue code 636 and 0636?
No. They are the same code. The UB-04 revenue code field has four digits, so the formal version includes a leading zero.

Does revenue code 636 require a HCPCS code?
Yes. Medicare claims processing instructions include an edit requiring HCPCS with 0636, and other payers commonly reject or return lines without one.

Does revenue code 636 need an NDC?
It depends on the payer. Original Medicare generally prices HCPCS-coded drugs without one, but requires NDC data on new unclassified drugs. Most Medicaid programs require it, and commercial rules follow the contract.

Can revenue code 636 be used on inpatient claims?
Under Medicare Part A, it is used for hemophilia clotting factors, which are paid as an add-on outside the normal DRG bundle. Other payers may allow broader use, so check the contract.

What is the difference between revenue code 250 and 636?
Revenue code 250 reports general pharmacy cost. Revenue code 636 reports a specific drug identified by a HCPCS code. Many facilities use 636 when a HCPCS code exists and 250 when one does not.

Is revenue code 636 used on a CMS-1500?
No. Revenue codes belong to institutional claims on the UB-04 and 837I. Professional claims on the CMS-1500 use HCPCS and CPT codes alone.

The Bottom Line on Revenue Code 636

Revenue code 636 exists so high-cost drugs get identified, priced, and paid on their own terms. The code itself is simple. The money is in the details around it: the right HCPCS code, units that follow the descriptor, a clean NDC where required, waste and 340B modifiers, and a status indicator you checked this quarter.

Key takeaways

• Use 0636 for drugs that carry a HCPCS code, and keep 0250 for those that do not.
• Medicare outpatient claims report all HCPCS-coded drugs under 0636, packaged or not.
• Medicare inpatient use is limited to hemophilia clotting factors.
• Bill units by the HCPCS descriptor, never by the vial.
• Watch the 340B proposal and the pass-through expirations coming at the end of 2026.

If drug lines are where your denials cluster, The Billing Advisors can review your claims and show you where the gaps are.